Movano Inc. (NASDAQ:MOVE) Sees Large Decrease in Short Interest

Movano Inc. (NASDAQ:MOVE) was the target of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 21,839 shares, a decline of 36.4% from the February 12th total of 34,360 shares. Currently, 2.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 46,049 shares, the short-interest ratio is presently 0.5 days. Based on an average daily trading volume, of 46,049 shares, the short-interest ratio is presently 0.5 days. Currently, 2.1% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Wall Street Zen raised Movano from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a research note on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Movano News Roundup

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Short‑term technical strength: the share price is trading above both its 50‑day ($11.82) and 200‑day ($9.30) simple moving averages, a signal that traders often treat as a buy trigger for momentum trades.
• Positive Sentiment: Low float / micro‑cap dynamics can amplify small buy orders into visible price gains — helpful for quick upside when there’s even modest demand.
• Neutral Sentiment: Healthcare/biotech headlines remain active (which can lift investor interest in small medical names), but recent items are about large-cap drugmakers and lifecycle plays rather than Movano specifically. Pfizer’s New Tafamidis Tablet Study Signals Strategic Lifecycle Move for PFE
• Neutral Sentiment: Broader market sentiment pieces (e.g., on payments/tech or macro headlines) can shift risk appetite and small‑cap flows that move names like MOVE, but they’re indirect drivers. Why PayPal’s Rally Faded—And What Could Restart It
• Neutral Sentiment: Geopolitical and commodity stories (oil/tankers, crypto volatility) are keeping overall market volatility elevated — that can produce intermittent demand for and selling of speculative small caps. Trump’s Move to Seize Oil Tankers Costs the U.S. Tens of Millions of Dollars
• Negative Sentiment: Very light trading today (≈18.8k shares vs. ~1.24M average) means the move may be ephemeral — a handful of trades can swing the price on a micro‑cap.
• Negative Sentiment: Company fundamentals remain a risk: tiny market cap, negative earnings, and a large 52‑week high/low spread imply high execution and liquidity risk for investors holding through volatility.

Movano Price Performance

MOVE stock traded up $0.21 during trading on Friday, reaching $13.24. 18,805 shares of the company were exchanged, compared to its average volume of 45,507. Movano has a twelve month low of $4.67 and a twelve month high of $34.87. The company has a market capitalization of $15.09 million, a price-to-earnings ratio of -1.22 and a beta of 0.86. The company has a 50-day moving average of $11.91 and a two-hundred day moving average of $9.35.

Insider Activity at Movano

In other Movano news, CEO John Mastrototaro sold 33,069 shares of the firm’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total transaction of $687,835.20. Following the transaction, the chief executive officer owned 56,114 shares in the company, valued at $1,167,171.20. This trade represents a 37.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CTO Michael Aaron Leabman sold 6,845 shares of Movano stock in a transaction on Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the transaction, the chief technology officer directly owned 22,639 shares of the company’s stock, valued at $150,775.74. This represents a 23.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 94,383 shares of company stock worth $1,524,933. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new position in Movano Inc. (NASDAQ:MOVE) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano as of its most recent SEC filing. Institutional investors and hedge funds own 16.64% of the company’s stock.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.